TY - JOUR T1 - Outcomes of atrial fibrillation hospitalizations in patients with systemic lupus erythematosus: a report from the national inpatient sample JF - Journal of Investigative Medicine JO - J Investig Med SP - 838 LP - 842 DO - 10.1136/jim-2020-001707 VL - 69 IS - 4 AU - Mavi Maureen Rivera Pavon AU - Anoj Shahi AU - Emmanuel Akuna AU - Iriagbonse Rotimi Asemota AU - Abdul Wahab Arif AU - Andrea Torres AU - Mahmoud Elbermawy AU - Genaro Velazquez AU - Muhammad Usman Almani AU - Muhammad Usman AU - Karol Quelal AU - Mohammad Waqas Bashir AU - Pius Ehiremen Ojemolon AU - Precious Obehi Eseaton Y1 - 2021/04/01 UR - http://hw-f5-jim.highwire.org/content/69/4/838.abstract N2 - This study compares outcomes of patients admitted for atrial fibrillation (AF) with and without coexisting systemic lupus erythematosus (SLE). The primary outcome was inpatient mortality. Hospital length of stay (LOS), total hospital charges, odds of undergoing ablation, pharmacologic cardioversion and electrical cardioversion were secondary outcomes of interest. Data were abstracted from the National Inpatient Sample (NIS) 2016 and 2017 database. The NIS was searched for adult hospitalizations with AF as principal diagnosis with and without SLE as secondary diagnosis using International Classification of Diseases, Tenth Revision, Clinical Modification codes. Multivariate logistic and linear regression analysis was used accordingly to adjust for confounders. There were over 71 million discharges included in the combined 2016 and 2017 NIS database. 821,630 hospitalizations were for adult patients, who had a principal diagnosis of AF, out of which, 2645 (0.3%) had SLE as secondary diagnosis. Hospitalizations for AF with SLE had similar inpatient mortality (1.5% vs 0.91%, adjusted OR (AOR): 1.0, 95% CI 0.47 to 2.14, p=0.991), LOS (4.2 vs 3.4 days, p=0.525), total hospital charges ($51,351 vs $39,121, p=0.056), odds of undergoing pharmacologic cardioversion (0.38% vs 0.38%, AOR: 0.90, 95% CI 0.22 to 3.69, p=0.880) and electrical cardioversion (12.9% vs 17.5%, AOR 0.87, 95% CI 0.66 to 1.15, p=0.324) compared with those without SLE. However, SLE group had increased odds of undergoing ablation (6.8% vs 4.2%, AOR: 1.9, 95% CI 1.3 to 2.7, p<0.0001). Patients admitted for AF with SLE had similar inpatient mortality, LOS, total hospital charges, likelihood of undergoing pharmacologic and electrical cardioversion compared with those without SLE. However, SLE group had greater odds of undergoing ablation.Data are available in a public, open access repository. Data obtained from the National Inpatient Sample. ER -